This report was first published by Endpoints News. To see the original version, click here
The latest biotech IPO comes in at a record high.
Kailera Therapeutics raised $625 million, topping the record set by Moderna’s public entrance. In 2018, Moderna put together a $604 million IPO. Kailera is only the second biotech IPO to surpass $600 million before options.
您已阅读32%（362字），剩余68%（781字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。